GSK plc Reports Transaction in Own Shares

TL;DR

GSK bought back its own shares, filing a 6-K on Aug 14, 2025.

AI Summary

GSK plc announced a transaction in its own shares on August 14, 2025. The filing, a Form 6-K, indicates the company is reporting on its activities as a foreign private issuer. Specific details of the share transaction, such as the number of shares or the value, are not provided in this excerpt.

Why It Matters

This filing signals GSK's engagement in share buybacks or other equity transactions, which can impact share count and investor returns.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of share transactions and does not contain negative financial news.

Key Players & Entities

• GSK plc (company) — Registrant
• August 2025 (date) — Reporting period
• 001-15170 (other) — Commission File Number

FAQ

Filing Documents

• a2473v.htm (6-K) — 1040KB
• 0001654954-25-009525.txt ( ) — 1042KB

From the Filing

IN OWN SHARES a2473v UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934       For the month of August 2025   Commission File Number 001-15170     GSK plc (Translation of registrant's name into English)     79 New Oxford Street, London, WC1A 1DG (Address of principal executive office)       Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.   Form 20-F . . . .X. . . . Form 40-F . . . . . . . .                                       Transaction in own shares   GSK plc (the " Company ") announces today   acting through its corporate stockbroker, Merrill Lynch International (the " Broker "), it has purchased the following number of the Company's ordinary shares of  31¼  pence each.     Date of purchase: 13 August 2025 Aggregate number of ordinary shares of  31¼  pence each purchased: 306,478 Lowest price paid per share (GBp): 1,411.50p Highest price paid per share (GBp): 1,434.50p Volume-weighted average price paid per share (GBp): 1,424.64p     The purchased shares will be held as Treasury shares.   Such purchase forms part of the Company's existing buyback programme and was effected pursuant to the non-discretionary agreement entered into with the Broker on 4 June 2025, as announced on 4 June 2025. Since 4 June 2025 the Company has purchased 23,204,716 ordinary shares.   Following the above purchase, the Company will hold 241,339,099 ordinary shares in treasury and have 4,074,052,147 ordinary shares in issue (excluding Treasury shares).   The total number of voting rights in the Company is   4,074,052,147. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.   The Company confirms that, in accordance with DTR 5.5.1R, following the above purchase the percentage of voting rights attributable to the ordinary shares held in treasury is   5.92 per cent.   The table below contains detailed information of the individual trades made by the Broker on the London Stock Exchange and the CBOE Europe Limited recognised investment exchange (through its order books having market identification codes CHIX or BATE) as part of the buyback programme.   Schedule of Purchases Shares purchased:      GSK plc (ISIN: GB00BN7SWP63) Date of purchases:     13 August 2025 Investment firm:        Merrill Lynch International   Aggregated information per trading venue: Venue Number of ordinary shares purchased Highest price paid (per ordinary share) (GBp) Lowest price paid (per ordinary share) (GBp) Volume weighted average price paid (per ordinary share) (GBp) London Stock Exchange (XLON) 306,478 1,434.50p 1,411.50p 1,424.64p CBOE (CHIX) 0 - - - CBOE (BATE) 0 - - -     Individual transactions:   Number ofShares Price per Share (GBp) Tradingvenue Date oftransaction Time oftransaction Transaction reference number 30 1,413.50  XLON 13-Aug-2025 08:00:23 0XL06D000000000088VTRU 150 1,413.50  XLON 13-Aug-2025 08:00:23 0XL064000000000088VTNS 426 1,413.50  XLON 13-Aug-2025 08:00:23 0XL064000000000088VTNO 426 1,413.50  XLON 13-Aug-2025 08:00:23 0XL06D000000000088VTRS 483 1,413.50  XLON 13-Aug-2025 08:00:23 0XL06A000000000088VTO9 571 1,413.00  XLON 13-Aug-2025 08:00:25 0XL061700000000088VTRE 123 1,412.00  XLON 13-Aug-2025 08:00:35 0XL064000000000088VTP6 373 1,412.00  XLON 13-Aug-2025 08:00:35 0XL06D000000000088VTTU 1,622 1,411.50  XLON 13-Aug-2025 08:00:35 0XL061700000000088VTTB 2,959 1,412.00  XLON 13-Aug-2025 08:00:35 0XL06A000000000088VTR6 8,466 1,412.50  XLON 13-Aug-2025 08:00:35 0XL064000000000088VTP7 60 1,417.50  XLON 13-Aug-2025 08:04:41 0XL064000000000088VU3G 164 1,417.50  XLON 13-Aug-2025 08:04:41 0XL06D000000000088VU7F 327 1,417.50  XLON 13-Aug-2025 08:04:41 0XL061700000000088VU44 410 1,416.50  XLON 13-Aug-2025 08:04:58 0XL06A000000000088VU7H 419 1,4

View Full Filing

View this 6-K filing on SEC EDGAR